Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Hout

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Progress in Cardiovascular Diseases|November 11, 1999
Economic evaluation in the field of cardiology: theory and practiceB A van Hout, E S Goes, E W Grijseels, et al.
Critical Care (London, England)|August 18, 2004
Prevalence and incidence of severe sepsis in Dutch intensive care unitsAukje van Gestel, Jan Bakker, Christiaan P W M Veraart, et al.
Journal of Health Services Research & Policy|September 4, 1996
Simulation models in the planning of health care facilities: an application in the case of neonatal extracorporeal membrane oxygenationB C Michel, R J van Staveren, W B Geven, et al.
Applied Health Economics and Health Policy|June 29, 2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulationsJ Floris S Logman, Bart M S Heeg, Johan Herlitz, et al.
Pharmacoeconomics|September 7, 2007
Long-term clopidogrel therapy in patients receiving percutaneous coronary interventionBart M S Heeg, Ron J G Peters, Marc Botteman, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|March 4, 2011
Cross-sectional study into the costs and impact on family functioning of 4-year-old children with aggressive behaviorMaartje A Raaijmakers, Jocelyne A Posthumus, Ben A van Hout, et al.
BMJ (Clinical Research Ed.)|July 26, 1997
Bone density and risk of hip fracture in men and women: cross sectional analysisC E De Laet, B A van Hout, H Burger, et al.
Pharmacoeconomics|September 19, 2002
Costs and effectiveness of using coumarins before, during and after coronary angioplastyJurrien M ten Berg, Johannas C Kelder, Thys H W Plokker, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term useR M Klok, M J Postma, B A van Hout, et al.
Journal of Market Access & Health Policy|July 24, 2018
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UKEmilie Clay, Aurélien Jamotte, Peter Verhamme, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Progress in Cardiovascular Diseases|November 11, 1999
Economic evaluation in the field of cardiology: theory and practiceB A van Hout, E S Goes, E W Grijseels, et al.
Critical Care (London, England)|August 18, 2004
Prevalence and incidence of severe sepsis in Dutch intensive care unitsAukje van Gestel, Jan Bakker, Christiaan P W M Veraart, et al.
Journal of Health Services Research & Policy|September 4, 1996
Simulation models in the planning of health care facilities: an application in the case of neonatal extracorporeal membrane oxygenationB C Michel, R J van Staveren, W B Geven, et al.
Applied Health Economics and Health Policy|June 29, 2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulationsJ Floris S Logman, Bart M S Heeg, Johan Herlitz, et al.
Pharmacoeconomics|September 7, 2007
Long-term clopidogrel therapy in patients receiving percutaneous coronary interventionBart M S Heeg, Ron J G Peters, Marc Botteman, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|March 4, 2011
Cross-sectional study into the costs and impact on family functioning of 4-year-old children with aggressive behaviorMaartje A Raaijmakers, Jocelyne A Posthumus, Ben A van Hout, et al.
BMJ (Clinical Research Ed.)|July 26, 1997
Bone density and risk of hip fracture in men and women: cross sectional analysisC E De Laet, B A van Hout, H Burger, et al.
Pharmacoeconomics|September 19, 2002
Costs and effectiveness of using coumarins before, during and after coronary angioplastyJurrien M ten Berg, Johannas C Kelder, Thys H W Plokker, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term useR M Klok, M J Postma, B A van Hout, et al.
Journal of Market Access & Health Policy|July 24, 2018
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UKEmilie Clay, Aurélien Jamotte, Peter Verhamme, et al.
Pageof 12